TARS — Tarsus Pharmaceuticals, Inc. stock price, charts and financials

QT51Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
61.11
-0.21-0.34%
OverviewShort InterestFilings
TARSQT51Tarsus Pharmaceuticals, Inc.·NASDAQ
61.11-0.34%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 13, 20268-KCurrent report
Jul 08, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 06, 20268-KCurrent report
#1 / 25 of 444
Page
▼
/ 18